1. Turner D, Griffiths AM. Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis. Curr Gastroenterol Rep. 2009; 11:234–237. PMID:
19463224.
Article
2. Korelitz BI, Waye JD, Kreuning J, et al. Crohn's disease in endoscopic biopsies of the gastric antrum and duodenum. Am J Gastroenterol. 1981; 76:103–109. PMID:
7304545.
3. Cameron DJ. Upper and lower gastrointestinal endoscopy in children and adolescents with Crohn's disease: a prospective study. J Gastroenterol Hepatol. 1991; 6:355–358. PMID:
1912443.
Article
4. Halme L, Kärkkäinen P, Rautelin H, Kosunen TU, Sipponen P. High frequency of helicobacter negative gastritis in patients with Crohn's disease. Gut. 1996; 38:379–383. PMID:
8675090.
Article
5. Sonnenberg A, Melton SD, Genta RM. Frequent occurrence of gastritis and duodenitis in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011; 17:39–44. PMID:
20848539.
Article
6. Genta RM, Sonnenberg A. Non-
Helicobacter pylori gastritis is common among paediatric patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012; 35:1310–1316.
Article
7. el-Omar E, Penman I, Cruikshank G, et al. Low prevalence of
Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut. 1994; 35:1385–1388. PMID:
7959192.
Article
8. Mantzaris GJ, Archavlis E, Zografos C, Zavos K, Petraki K, Triadaphyllou G. Low prevalence of
Helicobacter pylori in inflammatory bowel disease: association with sulfasalazine. Am J Gastroenterol. 1995; 90:1900. PMID:
7572928.
9. Wagtmans MJ, Witte AM, Taylor DR, et al. Low seroprevalence of
Helicobacter pylori antibodies in historical sera of patients with Crohn's disease. Scand J Gastroenterol. 1997; 32:712–718. PMID:
9246713.
Article
10. Meining A, Bayerdörffer E, Bastlein E, et al. Focal inflammatory infiltrations in gastric biopsy specimens are suggestive of Crohn's disease. Crohn's Disease Study Group, Germany. Scand J Gastroenterol. 1997; 32:813–818. PMID:
9282974.
Article
11. Parente F, Molteni P, Bollani S, et al. Prevalence of
Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching. Scand J Gastroenterol. 1997; 32:1140–1146. PMID:
9399396.
Article
12. Parente F, Cucino C, Bollani S, et al. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role. Am J Gastroenterol. 2000; 95:705–711. PMID:
10710061.
Article
13. Väre PO, Heikius B, Silvennoinen JA, et al. Seroprevalence of
Helicobacter pylori infection in inflammatory bowel disease: is
Helicobacter pylori infection a protective factor? Scand J Gastroenterol. 2001; 36:1295–1300. PMID:
11761020.
14. Guslandi M, Fanti L, Testoni PA.
Helicobacter pylori seroprevalence in Crohn's disease: lack of influence by pharmacological treatment. Hepatogastroenterology. 2002; 49:1296–1297. PMID:
12239929.
15. Triantafillidis JK, Gikas A, Apostolidiss N, Merikas E, Mallass E, Peros G. The low prevalence of
helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment. Am J Gastroenterol. 2003; 98:1213–1214. PMID:
12809861.
Article
16. Prónai L, Schandl L, Orosz Z, Magyar P, Tulassay Z. Lower prevalence of
Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role. Helicobacter. 2004; 9:278–283. PMID:
15165265.
Article
17. Sładek M, Jedynak-Wasowicz U, Wedrychowicz A, Kowalska-Duplaga K, Pieczarkowski S, Fyderek K. The low prevalence of
Helicobacter pylori gastritis in newly diagnosed inflammatory bowel disease children and adolescent. Przegl Lek. 2007; 64(Suppl 3):65–67. PMID:
18431918.
18. Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000; 43(Suppl 10):S85–S93. PMID:
11052483.
19. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008; 14:542–549. PMID:
17941073.
Article
20. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008; 103:3167–3182. PMID:
19086963.
Article
21. Chuang CH, Lin SH, Chen CY, Sheu BS, Kao AW, Wang JD. Increasing incidence and lifetime risk of inflammatory bowel disease in Taiwan: a nationwide study in a low-endemic area 1998-2010. Inflamm Bowel Dis. 2013; 19:2815–2819. PMID:
24141711.
Article
22. Park SH, Yang SK, Park SK, et al. Long-term prognosis of Crohn's disease and its temporal change between 1981 and 2012: a hospital-based cohort study from Korea. Inflamm Bowel Dis. 2014; 20:488–494. PMID:
24412992.
Article
23. Ng SC, Tsoi KK, Kamm MA, et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis. 2012; 18:1164–1176. PMID:
21887729.
Article
24. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology. 1998; 114:1161–1168. PMID:
9609752.
Article
25. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55:749–753. PMID:
16698746.
Article
26. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70:439–444. PMID:
1248701.
27. Sostegni R, Daperno M, Scaglione N, Lavagna A, Rocca R, Pera A. Review article: Crohn's disease: monitoring disease activity. Aliment Pharmacol Ther. 2003; 17(Suppl 2):11–17. PMID:
12786607.
28. Park HK, Kim N, Lee SW, et al. The distribution of endoscopic gastritis in 25,536 heath check-up subjects in Korea. Korean J Helicobacter Up Gastrointest Res. 2012; 12:237–243.
29. Van Assche G, Dignass A, Panes J, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis. 2010; 4:7–27. PMID:
21122488.
Article
30. Hasni SA. Role of
Helicobacter pylori infection in autoimmune diseases. Curr Opin Rheumatol. 2012; 24:429–434. PMID:
22617822.
31. Chen Y, Blaser MJ.
Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis. 2008; 198:553–560. PMID:
18598192.
Article
32. Reibman J, Marmor M, Filner J, et al. Asthma is inversely associated with
Helicobacter pylori status in an urban population. PLoS One. 2008; 3:e4060. DOI:
10.1371/journal.pone.0004060. PMID:
19112508.
33. Luther J, Dave M, Higgins PD, Kao JY. Association between
Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis. 2010; 16:1077–1084. PMID:
19760778.
Article
34. Furusu H, Murase K, Nishida Y, et al. Accumulation of mast cells and macrophages in focal active gastritis of patients with Crohn's disease. Hepatogastroenterology. 2002; 49:639–643. PMID:
12063959.
35. Song MJ, Park DI, Hwang SJ, et al. The Prevalence of
Helicobacter pylori Infection in Korean Patients with Inflammatory Bowel Disease, a Multicenter Study. Korean J Gastroenterol. 2009; 53:341–347. PMID:
19556840.
Article
36. Yamamoto T. Prevention of recurrence after surgery for Crohn's disease: efficacy of infliximab. World J Gastroenterol. 2010; 16:5405–5410. PMID:
21086556.
Article
37. Simillis C, Jacovides M, Reese GE, Yamamoto T, Tekkis PP. Meta-analysis of the role of granulomas in the recurrence of Crohn disease. Dis Colon Rectum. 2010; 53:177–185. PMID:
20087093.
Article
38. Kotze PG, Saad-Hossne R. Biological therapy for the prevention and treatment of postoperative endoscopic recurrence in Crohn's disease: time for acceptance? Intest Res. 2013; 11:256–260.
Article
39. Denoya P, Canedo J, Berho M, et al. Granulomas in Crohn's disease: does progression through the bowel layers affect presentation or predict recurrence? Colorectal Dis. 2011; 13:1142–1147. PMID:
20860713.
Article
40. Markowitz J, Kahn E, Daum F. Prognostic significance of epithelioid granulomas found in rectosigmoid biopsies at the initial presentation of pediatric Crohn's disease. J Pediatr Gastroenterol Nutr. 1989; 9:182–186. PMID:
2809938.
Article
41. De Matos V, Russo PA, Cohen AB, Mamula P, Baldassano RN, Piccoli DA. Frequency and clinical correlations of granulomas in children with Crohn disease. J Pediatr Gastroenterol Nutr. 2008; 46:392–398. PMID:
18367950.
Article
42. Wagtmans MJ, van Hogezand RA, Griffioen G, Verspaget HW, Lamers CB. Crohn's disease of the upper gastrointestinal tract. Neth J Med. 1997; 50:S2–S7. PMID:
9050325.
Article
43. Loftus EV Jr. Upper gastrointestinal tract Crohn's disease. Clin Perspect Gastroenterol. 2002; 5:188–191.
44. Kefalas CH. Gastroduodenal Crohn's disease. Proc (Bayl Univ Med Cent). 2003; 16:147–151. PMID:
16278730.
Article